INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Stryker Corporation

Levi & Korsinsky announces it has commenced an investigation of Stryker Corporation ("Stryker" or the "Company") SYK concerning possible violations of federal securities laws.

On July 17, 2017, the U.S. Food and Drug Administration issued a warning letter to Stryker citing "violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals." Then on August 23, 2017, Stryker Corporation announced a "voluntary product recall involving specific lots of Oral Care products sold through the company's Sage Products business unit (Sage)." The recall is due to a potential for "cross-contamination of Oral Care solutions" by a third-party supplier. To obtain additional information, go to:

http://www.zlkdocs.com/SYK-Info-Request-Form-6053

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170830006147/en/